BRIEF published on 08/02/2024 at 13:31, 1 year 4 months ago CRIT: Information on voting rights and share capital Share Capital Voting Rights Actions AMF CRIT
BRIEF published on 05/31/2024 at 08:34, 1 year 6 months ago Approval of the Offer Document for Openjobmetis S.p.A. Acceptance Period Tender Offer Openjobmetis Payment Date CONSOB
PRESS RELEASE published on 05/31/2024 at 08:29, 1 year 6 months ago Openjobmetis s.p.a.- Approval of the offer document Plavisgas S.r.l. and CRIT S.A.S. announce approval of the offer document for mandatory public tender offer on Openjobmetis S.p.A. shares. Acceptance Period starts on June 10, 2024 Public Tender Offer Offer Document CRIT S.A.S. Plavisgas S.r.l. Openjobmetis S.p.A.
BRIEF published on 05/17/2024 at 10:46, 1 year 6 months ago CRIT announces the availability of documents for its Combined General Meeting Shareholders General Assembly Trade Code Preparatory Documents CRIT
Published on 12/05/2025 at 02:35, 2 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
